Form 4: AngioDynamics Executive Sells 4,060 Shares of Common Stock

Warren Nighan JR, SVP of Quality and Regulatory at AngioDynamics, sold 4,060 shares of common stock at a price of $12.31 per share on January 16, 2025.

Summary

• Warren Nighan JR, a Senior Vice President at AngioDynamics, sold 4,060 shares of the company's common stock.
• The sale occurred on January 16, 2025.
• The price per share was $12.31.
• Following the transaction, Mr. Nighan directly owns 41,817 shares of AngioDynamics common stock.

Sentiment

Score: 5

Explanation: The document is a neutral report of an insider stock sale, which is a common occurrence. It doesn't indicate any positive or negative sentiment about the company's performance.

Industry Context

This is a routine SEC Form 4 filing, which is common for corporate insiders who trade company stock. It provides transparency into the transactions of company executives.

Comparison to Industry Standards

• SEC Form 4 filings are standard practice for publicly traded companies in the United States.
• The transaction is typical for executives who may sell shares for personal financial management or diversification purposes.
• The sale is not unusual in comparison to similar filings from other companies.

Stakeholder Impact

• The sale of shares by an executive may have a minor impact on shareholder sentiment, but is generally considered a normal part of executive compensation and personal financial planning.

Key Dates

Keywords

AngioDynamics, stock sale, insider trading, executive, Warren Nighan JR, SVP Quality and Regulatory, common stock